What is the new non-opioid painkiller approved by the FDA? It’s called suzetrigine, brand name Journavx. The FDA approved it in January 2025 for moderate-to-severe acute pain in adults. And the reason it matters so much is that it’s the first genuinely new class of non-opioid painkiller to get approval in over twenty years. To... Read More

How much have cancer survival rates improved? This progress is not limited to oncology; we are seeing a similar pharmaceutical breakthrough in other fields as well, such as the development of non-addictive pain relief They’ve roughly doubled over the last fifty years which is genuinely impressive when you sit with the number for a minute.... Read More

What is personalised gene editing and who received it first? Personalised gene editing is exactly what it sounds like, designing a one-off genetic treatment for a single patient’s specific mutation. Not a drug that thousands of people can take. A bespoke therapy built for one person and one person only. The first recipient was a... Read More